Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Dow
Boehringer Ingelheim
Healthtrust
Express Scripts
Federal Trade Commission
Merck
Teva
Mallinckrodt

Generated: December 13, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MINOCYCLINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Minocycline Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00029874 Minocycline in Patients With Huntington's Disease Completed FDA Office of Orphan Products Development Phase 1/Phase 2 This is a study to determine whether treatment with minocycline is safe and tolerable in patients with Huntington's disease (HD) and whether minocycline reduces symptoms of HD in these patients.
NCT00047723 Minocycline to Treat Amyotrophic Lateral Sclerosis Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 3 The purpose of this trial is to test the safety, tolerability, and effectiveness of minocycline compared to placebo in patients with amyotrophic lateral sclerosis (ALS).
NCT00063193 National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 2 The goal of this study is to assess the impact of minocycline and creatine on the progression of Parkinson's disease, in order to determine whether it is reasonable to proceed with further study of either of these agents.
NCT00063193 National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial Completed University of Rochester Phase 2 The goal of this study is to assess the impact of minocycline and creatine on the progression of Parkinson's disease, in order to determine whether it is reasonable to proceed with further study of either of these agents.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Allergan Phase 4 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Minocycline Hydrochloride

Condition Name

Condition Name for Minocycline Hydrochloride
Intervention Trials
Schizophrenia 11
Acne Vulgaris 11
Healthy 5
Schizoaffective Disorder 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Minocycline Hydrochloride
Intervention Trials
Schizophrenia 13
Depressive Disorder 13
Depression 13
Acne Vulgaris 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Minocycline Hydrochloride

Trials by Country

Trials by Country for Minocycline Hydrochloride
Location Trials
United States 337
Canada 22
Germany 13
Israel 10
Pakistan 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Minocycline Hydrochloride
Location Trials
Texas 27
New York 25
California 21
North Carolina 18
Maryland 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Minocycline Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Minocycline Hydrochloride
Clinical Trial Phase Trials
Phase 4 28
Phase 3 29
Phase 2/Phase 3 3
[disabled in preview] 70
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Minocycline Hydrochloride
Clinical Trial Phase Trials
Completed 71
Recruiting 40
Unknown status 22
[disabled in preview] 31
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Minocycline Hydrochloride

Sponsor Name

Sponsor Name for Minocycline Hydrochloride
Sponsor Trials
M.D. Anderson Cancer Center 13
National Cancer Institute (NCI) 11
Foamix Ltd. 10
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Minocycline Hydrochloride
Sponsor Trials
Other 253
Industry 61
NIH 30
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Boehringer Ingelheim
Mallinckrodt
Argus Health
UBS
US Department of Justice
Healthtrust
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.